Reduced levels of pulmonary surfactant in COVID-19 ARDS

Sci Rep. 2022 Mar 8;12(1):4040. doi: 10.1038/s41598-022-07944-4.

Abstract

To provide novel data on surfactant levels in adult COVID-19 patients, we collected bronchoalveolar lavage fluid less than 72 h after intubation and used Fourier Transform Infrared Spectroscopy to measure levels of dipalmitoylphosphatidylcholine (DPPC). A total of eleven COVID-19 patients with moderate-to-severe ARDS (CARDS) and 15 healthy controls were included. CARDS patients had lower DPPC levels than healthy controls. Moreover, a principal component analysis was able to separate patient groups into distinguishable subgroups. Our findings indicate markedly impaired pulmonary surfactant levels in COVID-19 patients, justifying further studies and clinical trials of exogenous surfactant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1,2-Dipalmitoylphosphatidylcholine / analysis
  • Adult
  • Aged
  • Bronchoalveolar Lavage Fluid / chemistry*
  • COVID-19 / pathology*
  • COVID-19 / virology
  • Case-Control Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Principal Component Analysis
  • Pulmonary Surfactants / analysis*
  • Pulmonary Surfactants / metabolism
  • SARS-CoV-2 / isolation & purification
  • Severity of Illness Index
  • Spectrophotometry, Infrared / methods

Substances

  • Pulmonary Surfactants
  • 1,2-Dipalmitoylphosphatidylcholine